honokiol has been researched along with Glioma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chang, KC; Hsu, YC; Lin, FH; Shyong, YJ | 1 |
Chen, GR; Cheng, L; Gu, LY; Ju, RJ; Li, XT; Liu, S; Song, XL; Wang, X; Xiao, Y; Zhang, SM | 1 |
Chang, CK; Chen, KY; Chen, RM; Chio, CC; Chuang, JY; Liu, CC; Liu, SH | 1 |
Chen, RM; Chio, CC; Liu, SH; Mohanraj, M; Tai, YT; Yang, ST | 1 |
Chen, RM; Chen, TL; Hsieh, MH; Lin, CJ; Lin, YW; Tseng, YY; Wu, GJ | 1 |
Chen, L; Deng, C; Deng, L; Duan, X; Peng, C; Wang, N; Wang, X; Wei, Y; Wen, J; Yang, G; Zhang, X; Zhao, X; Zheng, H | 1 |
6 other study(ies) available for honokiol and Glioma
Article | Year |
---|---|
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment.
Topics: Drug Delivery Systems; Durapatite; Glioma; Humans; Porosity | 2023 |
Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biphenyl Compounds; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Daunorubicin; Drug Liberation; Glioma; Lactoferrin; Lignans; Liposomes; Mice, Inbred ICR; Rats | 2017 |
Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Biphenyl Compounds; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Glioma; Humans; Lignans; Temozolomide | 2018 |
Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
Topics: Animals; Apoptosis; Biphenyl Compounds; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Dacarbazine; DNA Fragmentation; Drugs, Chinese Herbal; Fas Ligand Protein; Glioma; Humans; Lignans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Reactive Oxygen Species; Signal Transduction; Temozolomide | 2018 |
Honokiol induces autophagic cell death in malignant glioma through reactive oxygen species-mediated regulation of the p53/PI3K/Akt/mTOR signaling pathway.
Topics: Adenine; Animals; Apoptosis; Ascorbic Acid; Autophagy; Biphenyl Compounds; Caspase 3; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Glioma; Lignans; Mice; Microtubule-Associated Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2016 |
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Female; Glioma; Gliosarcoma; Humans; Lignans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Rats; Rats, Inbred F344; Rats, Sprague-Dawley | 2011 |